{"entity":{"type":"insider","cik":"0001765710","url":"/insider/0001765710","json_url":"/insider/0001765710.json","name":"Qiming U.S. Healthcare Fund II, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2021-07-01","last":"2023-04-11","span_basis":"filed_date"},"name_variants":[{"name":"Qiming U.S. Healthcare Fund II, L.P.","source":"filing","n_filings":3,"first_seen":"2021-07-01","last_seen":"2023-04-11"}],"transactions":[{"id":8463683,"accession":"0001209191-23-024058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-024058","line_url":"/filing/0001209191-23-024058#line-1","is_derivative":false,"issuer_cik":"0001242126","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001242126","owner_cik":null,"owner_name":"Qiming U.S. Healthcare GP II, LLC; RIESCHEL GARY E; MCDADE MARK; Qiming U.S. Healthcare Fund II, L.P.","owner_display_name":"Qiming U.S. Healthcare GP II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2666666.0,"shares_display":"2,666,666","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":3999999.0,"total_display":"3,999,999.00","total_whole":"3,999,999","shares_owned_after":8519648.0,"shares_owned_after_display":"8,519,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-04-11","scope":"insider"},{"id":4709080,"accession":"0000899243-21-031149","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-031149","line_url":"/filing/0000899243-21-031149","is_derivative":false,"issuer_cik":"0001242126","issuer_name":"Icosavax, Inc.","issuer_ticker":"ICVX","issuer_name_source":null,"issuer_url":"/issuer/0001242126","owner_cik":null,"owner_name":"Qiming U.S. Healthcare GP II, LLC; Qiming U.S. Healthcare Fund II, L.P.; MCDADE MARK","owner_display_name":"Qiming U.S. Healthcare GP II, LLC","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":221351.0,"shares_display":"221,351","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3320265.0,"total_display":"3,320,265.00","total_whole":"3,320,265","shares_owned_after":3510228.0,"shares_owned_after_display":"3,510,228","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-02","filed_date":"2021-08-02","scope":"insider","n_lines":3},{"id":5293171,"accession":"0001209191-21-044606","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-044606","line_url":"/filing/0001209191-21-044606#line-3","is_derivative":false,"issuer_cik":"0001765710","issuer_name":"Elevation Oncology, Inc.","issuer_ticker":"ELEV","issuer_name_source":null,"issuer_url":"/issuer/0001765710","owner_cik":null,"owner_name":"Qiming U.S. Healthcare Fund II, L.P.; Qiming U.S. Healthcare GP II, LLC","owner_display_name":"Qiming U.S. Healthcare Fund II, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":2370142.0,"shares_owned_after_display":"2,370,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-07-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001788028","name":"Jasper Therapeutics, Inc.","url":"/issuer/0001788028","role":"Ten percent owner","n_filings":1,"first_seen":"2023-04-11","last_seen":"2023-04-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001786255","name":"Icosavax, Inc.","url":"/issuer/0001786255","role":"Other","n_filings":1,"first_seen":"2021-08-02","last_seen":"2021-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001783032","name":"Elevation Oncology, Inc.","url":"/issuer/0001783032","role":"Ten percent owner","n_filings":1,"first_seen":"2021-07-01","last_seen":"2021-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001765710","retrieved_at":"2026-08-22T11:48:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}